Related references
Note: Only part of the references are listed.Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukaemia?
Carl Inge Edvard Smith et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
Petra Langerbeins et al.
ACTA HAEMATOLOGICA (2021)
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Thomas Chatzikonstantinou et al.
LEUKEMIA (2021)
Clinical Trends Among US Adults Hospitalized With COVID-19, March to December 2020 A Cross-Sectional Study
Shikha Garg et al.
ANNALS OF INTERNAL MEDICINE (2021)
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Lindsey E. Roeker et al.
BLOOD (2021)
Systemic corticosteroids for the treatment of COVID-19
Carina Wagner et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Anthony R. Mato et al.
BLOOD (2020)
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Lydia Scarfo et al.
LEUKEMIA (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Andrew T. Levin et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
Krzysztof Piotr Malinowski et al.
FRONTIERS IN PHARMACOLOGY (2019)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)
M. Reinwald et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study
Paolo Strati et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2011)
A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients
Fabio Salvi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Infectious complications of chronic lymphocytic leukemia
PD Wadhwa et al.
SEMINARS IN ONCOLOGY (2006)